Sharpe ratio is not yet available for COEPW. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar stocks
The table compares Coeptis Therapeutics Holdings Inc's Sharpe Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how COEPW's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jul 11, 2026.
| Symbol | Name | 1Y Sharpe Ratio | 5Y Sharpe Ratio | 10Y Sharpe Ratio | All Time Sharpe Ratio |
|---|---|---|---|---|---|
| RVMDW | Revolution Medicines Inc. Warrant | 16.50 | |||
| ERAS | Erasca, Inc. | 10.83 | |||
| CLYM | Climb Bio Inc | 9.65 | |||
| SLGL | Sol-Gel Technologies Ltd. | 8.17 | |||
| DRTSW | Alpha Tau Medical Ltd. Warrant | 8.12 | |||
| STTK | Shattuck Labs, Inc. | 7.49 | |||
| SYRE | Spyre Therapeutics Inc. | 7.45 | |||
| ANRO | Alto Neuroscience, Inc | 7.30 | |||
| RLMD | Relmada Therapeutics, Inc. | 7.29 | |||
| LQDA | Liquidia Corporation | 6.91 | |||
| COEPW | Coeptis Therapeutics Holdings Inc | — |
Loading charts...
Sharpe Ratio Calculator
How does COEPW fit in your portfolio?
Add your other holdings to see your portfolio's Sharpe Ratio and find out.
Analyze Your Portfolio